This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of eyelid, including canthus
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 28 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 75.37 | 75.82 | 75.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 58
- Matched controls
- 581
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
80.4
57
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
16.4
15
*
L57.0
ICD-10 Finland
Actinic keratosis
15.3
15.3
27
31
TQW99
NOMESCO Finland
Other minor procedure on skin
31.7
13.9
18
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
25.3
13.1
18
10
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.0
12
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
39.5
12.4
15
5
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
11.9
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.9
11
*
CBA10
NOMESCO Finland
Biopsy of eyelid
54.6
11.5
13
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
74.1
11.1
12
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.7
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.7
10
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
12.9
10.6
19
21
ZXC15
NOMESCO Finland
Use of photodynamic technique
+∞
9.6
9
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
26.6
8.4
11
5
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.4
7
*
L04AA06
ATC
mycophenolic acid; systemic
+∞
7.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.4
7
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
30.3
6.4
8
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
6.4
6
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
6.4
6
*
127
Kela drug reimbursment
Transplant complication
+∞
6.4
6
*
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.4
6
*
ZXC50
NOMESCO Finland
Cryotherapy
14.7
6.4
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
46
114
11.38
21.36
4.1
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
22
30
10.57
16.36
1.9
1.2
—
—
—
0
0
(4035726)
14
12
14.59
14.00
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
99
4.77
8.74
2.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
42
5.13
6.85
2.2
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
15
7.70
6.51
1.0
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
32
5.30
6.11
1.6
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
34
152
3.59
6.06
10.3
4.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
33
146
3.56
5.96
5.9
4.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
42
231
3.31
5.10
10.5
4.5
e9/l
2.2
1.7
0.32
37
211
(3001604) Monocytes [#/volume] in Blood
41
226
3.21
4.89
10.7
4.4
e9/l
0.6
0.6
0.05
36
202
(3006315) Basophils [#/volume] in Blood
41
229
3.14
4.73
10.7
4.4
e9/l
0.0
0.0
0.06
36
206
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
67
3.59
4.71
1.9
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
67
3.59
4.71
1.9
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
41
236
3.00
4.37
11.0
4.4
e9/l
0.2
0.2
0.15
35
213
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
27
4.70
4.36
3.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
202
2.93
4.33
2.4
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
44
3.78
4.05
2.9
4.3
mmol/l
1.5
1.5
0.01
14
39
(3000991) Gas panel - Venous blood
13
39
3.92
4.01
5.3
7.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
101
2.98
3.94
3.2
2.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
25
4.55
3.86
3.0
6.1
mmol/l
23.9
24.9
—
10
19
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
38
220
2.75
3.85
2.5
2.1
pmol/l
89.1
90.8
0.09
24
100
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
39
231
2.72
3.74
8.9
5.0
mmol/l
1.2
1.2
0.09
33
201
(3015377) Calcium [Moles/volume] in Serum or Plasma
30
158
2.67
3.61
2.7
2.1
mmol/l
2.4
2.3
0.38
25
126
(3031040) Bacteria [#/volume] in Urine by Automated count
48
323
2.86
3.47
6.8
5.2
—
326.4
—
0
12
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
11
6.97
3.27
1.4
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
11
6.97
3.27
1.4
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
33
189
2.52
3.27
4.4
3.7
—
—
—
0
0
(3019225) pH of Specimen
13
45
3.36
3.24
5.4
4.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
57
448
3.21
3.02
31.4
15.9
mg/l
35.6
23.8
1.08
50
360
(3013707) Erythrocyte sedimentation rate by Westergren method
50
358
2.72
2.96
5.3
4.5
mm/h
20.2
14.4
0.98
44
322
(3044640) Blood type and Crossmatch panel - Blood
26
139
2.45
2.93
3.2
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
50
363
2.64
2.78
10.8
5.2
u/l
81.7
74.8
1.02
45
336
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
39
255
2.32
2.73
3.7
2.9
u/l
49.5
50.5
0.04
32
236
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
83
2.62
2.72
4.3
2.7
e6/l
0.6
0.9
0.27
12
44
(3003458) Phosphate [Moles/volume] in Serum or Plasma
16
70
2.71
2.67
11.7
5.5
mmol/l
1.1
1.0
0.48
16
60
(36304419) Bacteria [Presence] in Urine
24
129
2.36
2.63
6.4
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
26
3.85
2.59
2.7
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
58
473
3.10
2.56
33.3
18.5
umol/l
101.7
87.3
0.69
58
473
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
27
3.70
2.50
1.3
2.0
g/l
1.3
1.6
—
9
21
(3049717) Cytology report of Urine Cyto stain
7
17
4.48
2.43
3.6
2.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
31
193
2.16
2.35
14.3
8.4
e9/l
0.0
0.0
0.00
25
160
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
18
4.22
2.32
1.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
9
5.91
2.25
2.0
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
30
3.31
2.25
3.1
4.8
mmol/l
24.6
25.2
—
9
30
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
53
414
2.52
2.22
28.3
15.6
ml/min/173m2
67.5
69.7
0.30
48
338
(3019550) Sodium [Moles/volume] in Serum or Plasma
58
481
2.91
2.22
32.9
19.2
mmol/l
138.9
139.6
1.06
58
465
(3023103) Potassium [Moles/volume] in Serum or Plasma
58
483
2.86
2.22
33.8
19.2
mmol/l
4.0
4.0
0.39
58
465
(3030467) Casts [#/volume] in Urine by Automated count
24
138
2.17
2.19
6.5
3.1
e6/l
0.1
0.5
1.25
19
102
(3003327) Ova and parasites identified in Stool by Light microscopy
5
10
5.31
2.11
1.4
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
182
2.07
2.10
5.7
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
28
175
2.05
2.04
3.8
3.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
11
4.82
1.98
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
22
128
2.09
1.92
3.2
2.5
umol/l
394.7
3318.3
0.49
16
103
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
54
436
2.41
1.92
5.6
7.8
mmol/mol
39.5
41.9
0.97
48
397
(3018095) Leukocytes [#/volume] in Urine
28
179
1.99
1.89
7.1
4.0
e6/l
46.3
83.3
0.44
20
133
(3014007) Fractional oxyhemoglobin in Arterial blood
8
29
3.00
1.86
3.4
6.5
%
93.7
91.8
—
8
29
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
19
3.37
1.70
3.2
7.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
32
2.71
1.66
2.9
5.9
%
0.3
0.7
—
8
32
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
87
2.11
1.64
4.8
2.9
e6/l
0.5
1.7
—
10
47
(3022313) Gas panel - Capillary blood
7
26
2.89
1.63
6.3
4.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
33
2.62
1.60
3.4
5.8
%
1.4
1.7
—
8
33
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
104
2.01
1.57
3.3
3.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
12
59
2.27
1.55
3.1
5.3
kpa
11.8
10.7
0.46
12
54
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
12
59
2.27
1.55
3.1
5.3
kpa
5.0
5.1
0.10
12
54
(3013512) EKG study
25
163
1.87
1.54
4.9
4.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
11
53
2.29
1.48
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
51
419
2.01
1.48
4.7
4.5
mmol/l
1.1
1.2
0.56
45
363
(3037467) Urinalysis macro (dipstick) panel - Urine
43
335
1.84
1.47
8.3
4.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
16
3.29
1.46
5.2
3.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
56
480
2.20
1.46
16.7
9.1
u/l
21.3
22.7
0.40
51
458
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
53
442
2.08
1.46
5.2
5.0
mmol/l
4.1
4.3
1.00
47
393
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
54
455
2.10
1.42
5.8
5.6
mmol/l
2.3
2.5
0.86
48
396
(3009542) Hematocrit [Volume Fraction] of Blood
47
379
1.87
1.41
29.2
16.5
%
38.0
38.9
0.21
28
226
(3002582) Erythrocytes [#/volume] in Urine
24
162
1.76
1.30
6.6
3.3
e6/l
8.8
419.9
0.52
17
124
(40758558) Short blood count panel - Blood
18
111
1.86
1.29
8.4
4.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
13
72
2.01
1.26
2.1
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
20
2.62
1.17
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
41
2.08
1.13
1.1
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
76
1.89
1.08
4.7
2.7
%
19.8
21.5
0.25
13
68
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
23
161
1.66
1.07
2.4
2.1
u/l
55.3
58.5
0.15
18
147
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
51
437
1.78
1.06
5.3
5.0
mmol/l
1.4
1.4
0.39
45
382
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
22
2.37
1.05
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
37
2.00
0.97
1.7
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
49
420
1.68
0.97
4.6
4.7
mu/l
2.0
2.0
0.09
44
360
(3032080) INR in Blood by Coagulation assay
27
202
1.58
0.95
11.8
12.8
inr
1.3
1.5
—
5
65
(3015736) pH of Urine
25
184
1.58
0.94
3.3
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
64
1.87
0.93
2.7
2.4
ng/l
334.5
210.9
0.35
11
57
(3004789) Transferrin [Mass/volume] in Serum or Plasma
13
81
1.76
0.89
4.5
2.6
g/l
2.2
2.1
0.37
13
70
(40760892) CBC W Ordered Manual Differential panel - Blood
13
83
1.71
0.82
7.7
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
59
1.82
0.81
5.0
10.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
24
2.17
0.76
4.0
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
39
1.89
0.75
6.0
4.7
mmol/l
21.9
24.4
—
7
32
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
25
2.08
0.74
2.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
23
174
1.50
0.74
3.2
2.8
mg/l
32.3
89.0
1.15
18
105
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
26
2.00
0.72
1.2
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
42
1.75
0.71
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
42
1.75
0.71
1.1
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
43
1.70
0.69
1.1
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
28
1.85
0.67
1.4
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
11
71
1.66
0.67
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
10
63
1.69
0.66
3.2
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
52
470
1.53
0.63
27.8
14.9
—
—
—
0
0
(4010399)
5
30
1.72
0.62
1.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
24
189
1.43
0.62
3.5
3.7
mg/mmol
5.8
9.5
0.47
19
113
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
35
1.79
0.59
2.8
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
9
59
1.61
0.58
4.9
4.1
mmol/l
-0.5
1.6
—
9
45
(3022621) pH of Urine by Test strip
6
37
1.68
0.57
2.8
2.6
—
—
—
0
0
(3012544) pH of Venous blood
9
63
1.50
0.55
4.9
4.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
40
1.55
0.53
2.5
2.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.41
0.0
3.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
17
0.00
0.41
0.0
4.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
10
73
1.44
0.37
2.2
2.6
%
1.6
1.5
—
10
64
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
49
454
1.32
0.37
5.9
5.2
mmol/l
6.0
6.2
0.20
43
394
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
233
1.27
0.36
6.1
4.8
ng/l
32.3
37.1
0.28
21
186
(1761868) Lipid panel - Serum or Plasma
10
131
0.72
0.35
3.4
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
16
134
1.26
0.26
5.0
2.8
u/l
35.0
30.9
0.53
16
128
(3000492) Spirometry study
5
39
1.31
0.23
1.6
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
11
89
1.28
0.22
2.6
1.6
s
29.6
30.4
0.27
11
82
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
41
1.24
0.22
2.6
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
91
1.25
0.19
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
61
1.17
0.18
4.7
3.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
12
134
0.87
0.10
5.3
4.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
8
75
1.08
0.08
1.0
1.3
iu/ml
—
37.3
—
0
27
(3044889) 12 lead EKG panel
35
337
1.08
0.07
5.3
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
190
0.93
0.04
4.5
4.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
162
1.07
0.02
3.8
3.6
%
22.8
25.2
0.28
12
79
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
5.0
—
7.6
—
0
6
(3044290) Cell count panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
72.8
—
0
8
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002224) Polysomnography panel
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
12.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
6.9
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
2.6
—
13.1
—
0
5
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
24.3
—
0
5
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID_EXALLC – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).